Breaking News

Ardena Launches following Pharmavize and Crystallics Merger

Will offer solid-state chemistry, analytical and formulation development, and early-phase clinical supply manufacturing

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

A new early-phase contract development and manufacturing organization (CDMO), Ardena, has launched following the merging of Pharmavize and Crystallics. The two companies came together in 2016 with backing from investor Mentha Capital. The new brand name, Ardena, reveals the increased service offering and complementary capabilities of Pharmavize in Belgium and Crystallics in the Netherlands. The new company will deliver integrated services that include a.o. solid-state chemistry, analytical...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters